In patients on dialysis, the use of an injectable monoclonal antibody for prevention of osteoporosis-related fractures may increase the risk of MACE compared with oral bisphosphonates, observational ...
GAITHERSBURG, Maryland (Reuters) - Amgen Inc pledged on Thursday to closely monitor the long-term safety of its novel osteoporosis injection as U.S. advisers weighed the future of the company's most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback